You are here

  • Home
  • Archive
  • Volume 2, Issue 6
  • Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study

Article info

Article menu

Download PDFPDF

XML
Diabetes and endocrinology
Research
Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study

Authors

  • Greg A Carney Therapeutics Initiative, University of British Columbia, Vancouver, Canada PubMed articlesGoogle scholar articles
  • Ken Bassett Therapeutics Initiative, University of British Columbia, Vancouver, Canada Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada Department of Family Practice, University of British Columbia, Vancouver, Canada PubMed articlesGoogle scholar articles
  • James M Wright Therapeutics Initiative, University of British Columbia, Vancouver, Canada Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada Department of Medicine, University of British Columbia, Vancouver, Canada PubMed articlesGoogle scholar articles
  • Colin R Dormuth Therapeutics Initiative, University of British Columbia, Vancouver, Canada Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Greg Carney; greg.carney{at}ti.ubc.ca
View Full Text

Citation

Carney GA, Bassett K, Wright JM, et al
Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study
BMJ Open 2012;2:e001910. doi: 10.1136/bmjopen-2012-001910

Publication history

  • Received August 1, 2012
  • Accepted September 28, 2012
  • First published November 12, 2012.
Online issue publication 
October 26, 2017
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.